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  To study the inhibitory effect of guanidine compounds on cellular immunity， the PHA－induced
blastoid transformation of lymphQcytes of patients with chronic renal failure （CRF） on hemodialysis
（耳D）．・ゆr唖1⑳tig璽（HFいas examined．・and late「the stimulation indr・（SI）w・・c・1・・1・t・d・
’Se’ru！4．”ebnee’ntrat’ibn’of g“anidine 60mpounds was cohcomitantly measured． The SI was 39．80±
21．70， 60．27±22．05 and 61．09±16．32 for the HD， HF and healthy control groups， respectively．
Although． the value for the HD group was significantly lower than that for the HF group （p〈O．02）
or the control group （p〈O．OOI）， there was no difference between the HF and control groups． The
serum methylguanidine （MG） concentration for the HD group was S8．97±18．83 ptg／dl， which was
significantly higher than the 23．92 1 1．05 ptgfdl for the HF group． The SI and MG for the CRF patients
were inversely correlated． From these results， MG is considered to be one of the uremic toxins that
inhibit cellular immunity． Therefore， HF seems to be a better mode of therapy in that it improves
the cellular immunity of CRF patients by reducing the MG．
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群では15・73±IO．16 Ptgfdl， HF群では Z87土5．13
Ptg／dl，で危険率5％以下の有意差を認める． Gは
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Table 1．Serum guanidinocompounds， BUN and s－Cr in
hemodialysis and hemofiltration patients
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Relation between serum guanidinosuccinic acid and stimulation
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Relation between serum guanidinoacetic acidd and stimulation index
in hemodialysis and hemofiltration patient’s








  ● ●  oO
も  o












Relation between serum methylguanidine and stimulation index in
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Relation between serum guanidine and stimulation index in


















たGSA， GAA， G， MGのほかにguanidino propionic
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